Cancer survivors have more frequent and severe menopausal hot flashes

July 17, 2013

CLEVELAND, Ohio (July 17, 2013)--Women who survive cancer have more frequent, severe, and troubling hot flashes than other women with menopausal symptoms, according to a study published online today in Menopause, the journal of The North American Menopause Society (NAMS). But surprisingly, the cancer survivors fare better psychologically and report a better quality of life than the women without cancer and have about the same levels of sexual activity and function.

This is the first large-scale, clinic-based study to compare these groups of women using standard, validated questionnaires. It included 934 cancer survivors (about 90% survived breast cancer) and 155 participants without cancer who were patients at King Edward Memorial Hospital in Western Australia. The questionnaires, including the Green Climacteric Scale and Fallowfield's Sexual Activity Questionnaire, assessed hot flashes and other menopause-related symptoms and sexual function.

For the cancer survivors, hot flashes were much more frequent and severe. Seventy-six percent reported having hot flashes in the past 24 hours, compared with 54% of women without cancer. And 60% reported those hot flashes were severe or very severe, compared with 40% of the women without cancer. The authors pointed out that menopausal symptoms also seem to persist much longer in the cancer survivors, who often complained of menopausal symptoms many years after their cancer diagnosis.

But the study also offered some surprising findings: The cancer survivors were less troubled by psychological and physical symptoms and reported better quality of life than the women without cancer. In fact, the cancer survivors were less likely to have severe mood swings or sadness and reported significantly better social and family well-being. In addition, the cancer survivors had about the same levels of sexual activity and function, and just about as many (49%) reported severe vaginal dryness as women without cancer (47%). However, the survivors were more likely to attribute their sexual inactivity to "a physical problem that makes sexual relations difficult or uncomfortable."

That this study included women who may have undergone cancer therapy years before could help account for some of the surprising findings, say the authors. The cancer survivors' better emotional and social well-being may be the result of the good social and psychological support available for cancer survivors. Their similar rate of sexual problems did not mean the cancer survivors fared well--the rates were high in both groups.

NAMS Executive Director Margery Gass, MD, comments, "Both expected and surprising, these results highlight that all menopausal women, including cancer survivors, need effective treatment options for their hot flashes and sexual symptoms."
-end-
Supported by King Edward Memorial Hospital, AstraZeneca, the National Breast and Ovarian Cancer Center, and the National Breast Cancer Foundation of Australia, the study will be published in the March 2014 print edition of Menopause.

Founded in 1989, The North American Menopause Society (NAMS) is North America's leading nonprofit organization dedicated to promoting the health and quality of life of all women during midlife and beyond through an understanding of menopause and healthy aging. Its multidisciplinary membership of 2,000 leaders in the field--including clinical and basic science experts from medicine, nursing, sociology, psychology, nutrition, anthropology, epidemiology, pharmacy, and education--makes NAMS uniquely qualified to serve as the definitive resource for health professionals and the public for accurate, unbiased information about menopause and healthy aging. To learn more about NAMS, visit http://www.menopause.org.

The North American Menopause Society (NAMS)

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.